I am grateful to Charlotte de Meeûs for her summary below of the most extensive review of TPLF in the EU. It would look to me that the lack of firm support by the study for any of the 3 options it outlines (see below), probably makes it veer towards the first: which one that is, … Read more
Austin, TX, USA, April 7, 2025, CyberNewswire — SpyCloud, the leading identity threat protection company, today released new analysis of its recaptured darknet data repository that shows threat actors are increasingly bypassing endpoint protection solutions: 66% of malware infections occur on devices with endpoint security solutions installed. SpyCloud offers integrations with leading endpoint detection and … Read more
Austin, TX, Ma. 19, 2025, CyberNewswire — The average corporate user now has 146 stolen records linked to their identity, an average 12x increase from previous estimates, reflecting a surge in holistic identity exposures. SpyCloud, the leading identity threat protection company, today released its 2025 SpyCloud Annual Identity Exposure Report, highlighting the rise of darknet-exposed … Read more
By John Vandermosten, CFA NASDAQ:MDAI READ THE FULL MDAI RESEARCH REPORT Spectral AI, Inc. (NASDAQ:MDAI) reported topline data from its burn validation study in a March 17th press release confirming DeepView’s superior detection sensitivity relative to burn physicians. The announcement reminded stakeholders of the device’s background and development along with a description of the burn study’s … Read more
By Brad Sorensen, CFA NASDAQ:TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere caps. Previously reported preclinical tests have shown evidence that Telomir-1, the company’s primary therapy, can lengthen telomeres and initial animal testing illustrates the potential impact. … Read more